Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
about
Splice isoforms of alpha(1a)-adrenoceptor in rabbit.Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptorsFunctional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study.Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane bindingCorrelation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.Phenotype pharmacology of lower urinary tract α(1)-adrenoceptors.Native profiles of alpha(1A)-adrenoceptor phenotypes in rabbit prostate.Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout.Agonist pharmacology at recombinant α1A - and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors.Alpha 1-adrenoceptor pharmacome: alpha 1L-adrenoceptor and alpha 1A-adrenoceptor in the lower urinary tract.Pharmacologically distinct phenotypes of α1B -adrenoceptors: variation in binding and functional affinities for antagonists.Alpha-1D adrenoceptors are involved in reserpine-induced supersensitivity of rat tail artery.Expression of distinct alpha 1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits.Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats.Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes.Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.Effects of Silodosin and Tamsulosin on the Seminal Vesicle Contractile Response.
P2860
Q30862591-08051379-2736-4B3F-80CC-6A79236A8070Q34655702-816CBD92-6F07-4208-BBAB-E78093B1121AQ35044911-39BDB4A5-9F24-4461-9E95-ADB7190044C1Q35046091-4B684A77-4FC2-4144-8FE2-04816B52FC1EQ35049175-93450C85-004F-4323-A8B2-190C4BBBD1A4Q35183611-5534524D-1623-4999-93D7-84AFBEEF5199Q36024814-FD43BEE0-3560-4C9F-BC70-78671BFC6E6DQ37002332-0769AC09-EA16-4CDD-92E5-91D553DB641FQ37023846-0F583713-2574-43B3-99A9-2DCA1103DFD8Q37337881-4919EAC7-1500-4B98-8855-4DF67FA5EE23Q37582994-B336D7A4-222F-4DAF-AD13-6C79AD4E8D2AQ39176672-35A0926F-F2A7-4774-B68C-C1BDB800BBFAQ42122686-D8614EC6-63F3-43DD-A099-8B0C4CCC243FQ42156744-966F996A-F1AD-429A-B490-4C9DF12E0D4BQ42161649-1CB06D09-10BD-41FA-BDBB-3CFC7F2B3574Q42239574-84C62F00-49F8-48A1-A8F4-015F85FD8223Q43038673-5BCA1010-219F-4C86-A244-92B2F26DE972Q46637526-8A68E5F8-6BB9-4C68-A79B-B608BE6B5916
P2860
Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Pharmacological analysis of th ...... ty as a tritiated radioligand.
@en
Pharmacological analysis of th ...... ty as a tritiated radioligand.
@nl
type
label
Pharmacological analysis of th ...... ty as a tritiated radioligand.
@en
Pharmacological analysis of th ...... ty as a tritiated radioligand.
@nl
prefLabel
Pharmacological analysis of th ...... ty as a tritiated radioligand.
@en
Pharmacological analysis of th ...... ty as a tritiated radioligand.
@nl
P2093
P2860
P356
P1476
Pharmacological analysis of th ...... ty as a tritiated radioligand.
@en
P2093
I Muramatsu
T Taniguchi
P2860
P356
10.1038/SJ.BJP.0702489
P407
P577
1999-05-01T00:00:00Z